UnitedHealth Group (NYSE:UNH) Raised to “Neutral” at Robert W. Baird

UnitedHealth Group (NYSE:UNH) was upgraded by investment analysts at Robert W. Baird from an “underperform” rating to a “neutral” rating in a report released on Thursday, MarketBeat.com reports. The firm currently has a $453.00 price objective on the healthcare conglomerate’s stock, up from their previous price objective of $287.00. Robert W. Baird’s target price would indicate a potential upside of 6.24% from the company’s previous close.

A number of other brokerages have also recently issued reports on UNH. HSBC lifted their price objective on shares of UnitedHealth Group from $300.00 to $380.00 and gave the company a “hold” rating in a report on Monday, July 6th. Mizuho raised their price target on shares of UnitedHealth Group from $440.00 to $460.00 and gave the company an “outperform” rating in a research report on Monday, June 8th. Bank of America increased their price objective on UnitedHealth Group from $450.00 to $475.00 and gave the stock a “buy” rating in a research note on Wednesday, June 24th. Barclays lifted their target price on UnitedHealth Group from $373.00 to $429.00 and gave the company an “overweight” rating in a research report on Tuesday, May 26th. Finally, Royal Bank Of Canada increased their price target on UnitedHealth Group from $400.00 to $463.00 and gave the company an “outperform” rating in a research report on Thursday, July 9th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $447.29.

UnitedHealth Group Trading Up 0.7%

Shares of UnitedHealth Group stock opened at $426.39 on Thursday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.80 and a current ratio of 0.78. UnitedHealth Group has a 52 week low of $234.60 and a 52 week high of $461.62. The stock has a 50 day moving average price of $404.81 and a two-hundred day moving average price of $342.28. The stock has a market capitalization of $387.23 billion, a PE ratio of 27.44, a price-to-earnings-growth ratio of 1.58 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. The company had revenue of $112.03 billion for the quarter, compared to analysts’ expectations of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.UnitedHealth Group’s quarterly revenue was up .4% compared to the same quarter last year. During the same period last year, the business earned $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, equities analysts anticipate that UnitedHealth Group will post 19.75 earnings per share for the current fiscal year.

Insider Activity at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 800 shares of the firm’s stock in a transaction that occurred on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the transaction, the chief executive officer directly owned 17,805 shares of the company’s stock, valued at approximately $6,320,775. This trade represents a 4.30% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.28% of the company’s stock.

Hedge Funds Weigh In On UnitedHealth Group

Several hedge funds have recently made changes to their positions in the stock. Walker Asset Management LLC purchased a new stake in UnitedHealth Group during the 2nd quarter worth about $229,000. Ballast Inc. increased its position in shares of UnitedHealth Group by 11.4% during the second quarter. Ballast Inc. now owns 17,484 shares of the healthcare conglomerate’s stock valued at $7,267,000 after buying an additional 1,791 shares during the period. Regent Peak Wealth Advisors LLC boosted its position in shares of UnitedHealth Group by 21.3% in the second quarter. Regent Peak Wealth Advisors LLC now owns 1,620 shares of the healthcare conglomerate’s stock valued at $673,000 after acquiring an additional 285 shares during the period. Annex Advisory Services LLC grew its stake in UnitedHealth Group by 159.6% during the second quarter. Annex Advisory Services LLC now owns 68,577 shares of the healthcare conglomerate’s stock valued at $28,503,000 after acquiring an additional 42,157 shares in the last quarter. Finally, Whitener Capital Management Inc. lifted its stake in UnitedHealth Group by 43.0% in the 2nd quarter. Whitener Capital Management Inc. now owns 3,893 shares of the healthcare conglomerate’s stock worth $1,618,000 after purchasing an additional 1,171 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth beat Q2 estimates on earnings and revenue, driven by improved margins and lower medical costs, and raised its 2026 profit outlook. UnitedHealth shares surge on strong earnings beat and guidance
• Positive Sentiment: Morgan Stanley, Oppenheimer, UBS, RBC, and other firms lifted price targets after the results, signaling stronger Street confidence in the stock’s recovery. Analyst price target updates
• Positive Sentiment: Management doubled the 2026 share repurchase target to at least $5 billion, which may help support EPS and investor returns. What’s Fueling UNH Stock’s Rally? A Bigger Buyback, Higher Guidance – And CEO Says Turnaround Is ‘Returning To Form’
• Neutral Sentiment: Commentary around the earnings call says Medicare Advantage and Optum are improving, but commercial cost pressures could delay a full margin recovery. UnitedHealth Q2 Earnings Call Focuses on Reset and Durable Growth
• Negative Sentiment: Some analysts remain cautious, with at least one downgrade noting that the turnaround still faces execution risk despite the stronger quarter. UnitedHealth Group Q2: The Real Test Begins Now (Downgrade)

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.